Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Iproniazid-1-oxide | 4-Pyridinecarboxylic Acid 2-(1-Methylethyl)hydrazide 1-Oxide | 36781-38-1 | C9H13N3O2 | 195.22 | 4-Pyridinecarboxylic Acid 2-(1-Methylethyl)hydrazide 1-Oxide |
| Ipronidazole | 1-Methyl-2-(1-methylethyl)-5-nitro-1H-imidazole; 2-Isopropyl-1-methyl-5-nitro- imidazole; 1-Methyl-2-isopropyl-5-nitroimidazole; 2-Isopropyl-1-methyl-5-nitroimidazole; Ipronidazole; Ipropran; NSC 109212; Ro 07-1554; | 14885-29-1 | C7H11N3O2 | 169.11 | 1-Methyl-2-(1-methylethyl)-5-nitro-1H-imidazole; 2-Isopropyl-1-methyl-5-nitro- imidazole; 1-Methyl-2-isopropyl-5-nitroimidazole; 2-Isopropyl-1-methyl... |
| Lomustine Related Compound B | N-(2-Chloroethyl)-N’-cyclohexylurea; 1-(2-Chloroethyl)-3-cyclohexylurea; NSC 80352 | 13908-11-7 | C9H17ClN2O | 204.7 | N-(2-Chloroethyl)-N’-cyclohexylurea; 1-(2-Chloroethyl)-3-cyclohexylurea; NSC 80352 |
| Dabigatran Etexilate N-Oxide Inner Salt Discontinued | N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(1-oxido-2-pyridinyl)-beta-Alanine Ethyl Ester | 1381757-44-3 | C34H41N7O6 | 643.73 | N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(1-oxido-2-pyridinyl)-beta-Alanine E... |
| Z-L-Dab(Z)-OH | 55478-23-4 | C20H22N2O6 | 386.4 | ||
| dNAM CEP | (1R)-1,4-Anhydro-5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-1-C-(3-methoxy-2-naphthalenyl)-3-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]-D-erythro-pentitol; 3-(3-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyribofuranosyl)-2-methoxynaphthalene; | 1117893-10-3 | C46H53N2O7P | 776.9 | (1R)-1,4-Anhydro-5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-1-C-(3-methoxy-2-naphthalenyl)-3-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]-... |
| Dabrafenib | N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide; Dabarefenib; GSK 2118436; Tafinlar; | 1195765-45-7 | C23H20F3N5O2S2 | 519.56 | N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide; Dabarefenib; GSK 2118436; Tafinlar... |
| Dabrafenib-d9 | N-[3-[5-(2-Amino-4-pyrimidinyl)-2-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide; GSK 2118436-d9; Tafinlar-d9 | 1423119-98-5 | C23H11D9F3N5O2S2 | 528.62 | N-[3-[5-(2-Amino-4-pyrimidinyl)-2-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide; GSK 2118436-d9; Tafi... |
| Dabrafenib Mesylate | GSK 2118436 Methanesulfonate Salt; GSK 2118436B; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide Methanesulfonate | 1195768-06-9 | C24H24F3N5O5S3 | 615.67 | GSK 2118436 Methanesulfonate Salt; GSK 2118436B; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benze... |
| DACA | N-[2-(Dimethylamino)ethyl]-4-acridinecarboxamide; DACA; N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide; NSC 601316 | 89459-25-6 | C18H19N3O | 293.36 | N-[2-(Dimethylamino)ethyl]-4-acridinecarboxamide; DACA; N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide; NSC 601316
|
Page 1630 of 10017